Deenonpoe et al. [138] discovered in clinical trials on 20 patients that naringin exposed an inhibitory effect on TNF-α and IL-6 production, and these cytokines at a high-level cause immunological effects in psoriasis. Here, IL6 is linked to psoriasis.